Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Wednesday. Separately, HC Wainwright ...

FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling ...

AstraZeneca will obtain the full rights to Roxadustat in China, FibroGen said, adding that it will retain the US and other ...

Fibroblast activation protein α (FAP, also called seprase) is a prolyl-specific serine proteinase, highly upregulated in fibroblasts especially at sites of active tissue remodeling, including wound ...

The researchers suspect that cystatin B-like protein, carbonic anhydrase, tropomyosin, and peptidyl-prolyl cis-trans isomerase could potentially be behind these results. They write that “All FDA ...

After hours: 7:59:03 p.m. EST Loading Chart for AKBA ...

Pyroptosis is a special way of programmed cell death which is dependent on the activation of cysteinyl aspartate specific proteinase 1 (Caspase-1) and Caspase-4/5/11. Ferroptosis is an iron-dependent ...